| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,299 |
8,863 |
$470K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,346 |
11,139 |
$356K |
| 64483 |
|
3,036 |
2,405 |
$240K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,935 |
3,909 |
$143K |
| 64484 |
|
1,807 |
1,441 |
$52K |
| 77002 |
|
1,601 |
1,102 |
$43K |
| 64635 |
|
267 |
210 |
$37K |
| 20610 |
|
1,207 |
796 |
$34K |
| 64493 |
|
412 |
297 |
$29K |
| 64479 |
|
235 |
183 |
$21K |
| 64636 |
|
272 |
210 |
$15K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
854 |
660 |
$13K |
| 64494 |
|
268 |
192 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
294 |
222 |
$8K |
| 63650 |
|
18 |
12 |
$8K |
| 64480 |
|
191 |
156 |
$8K |
| 62370 |
|
329 |
195 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
349 |
311 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,243 |
2,511 |
$3K |
| 99152 |
|
341 |
263 |
$2K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
33 |
13 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
88 |
58 |
$551.92 |
| 99442 |
|
24 |
14 |
$300.92 |
| 96127 |
|
54 |
46 |
$103.97 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
68 |
45 |
$18.46 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
293 |
220 |
$2.58 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
29 |
28 |
$0.63 |
| 77003 |
|
23 |
12 |
$0.00 |
| 99406 |
|
79 |
72 |
$0.00 |